17-18161450-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_016239.4(MYO15A):c.9517+3G>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000479 in 1,461,190 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016239.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYO15A | NM_016239.4 | c.9517+3G>T | splice_region_variant, intron_variant | ENST00000647165.2 | NP_057323.3 | |||
MYO15A | XM_017024715.3 | c.9520+3G>T | splice_region_variant, intron_variant | XP_016880204.1 | ||||
MYO15A | XM_017024714.3 | c.9457+3G>T | splice_region_variant, intron_variant | XP_016880203.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYO15A | ENST00000647165.2 | c.9517+3G>T | splice_region_variant, intron_variant | NM_016239.4 | ENSP00000495481.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1461190Hom.: 0 Cov.: 32 AF XY: 0.00000413 AC XY: 3AN XY: 726936
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Oct 07, 2014 | Variant classified as Uncertain Significance - Favor Pathogenic. The c.9517+3G>T variant in MYO15A has been identified by our laboratory in trans with another v ariant of uncertain significance in MYO15A in two individuals with hearing loss in one family. It has not been identified in large population studies. This var iant is located in the 5' splice region. Computational tools suggest a possible impact to splicing. However, this information is not predictive enough to determ ine pathogenicity. In summary, while available data suggest that it is more like ly to be pathogenic, the clinical significance of this variant is uncertain. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at